-
COVID-19 mRNA-1273 Vaccination in the UK: A Comparative Modeling Study of Alternative Eligibility Criteria
Sep 9, 2025, 16:22 PM -
How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?
Sep 9, 2025, 16:22 PM -
Hospital Systemic Treatment for HepatoCarcinoma: The HOSTHECA Study
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
DARAH Project: Deploying a Datashield Federated Network in Real-World Healthcare Environments
Sep 9, 2025, 16:22 PM -
Current Status of Home-Healthcare Pilot Programs in South Korea and Policy Discussions for Institutionalization
Sep 9, 2025, 16:22 PM -
Prevalence of Migraine in India: A Meta-Analysis Based on Diagnostic Criteria and Gender Differences
Sep 9, 2025, 16:22 PM -
Adoption of AI Clinical Decision Support Systems in Primary Care: An Evaluation of Physician Acceptance
Sep 9, 2025, 16:22 PM -
Transportability of Overall Survival Estimates From the United States to Germany in EGFRm Advanced NSCLC Patients Post-Tyrosine Kinase Inhibitor (TKI) Treatment
Sep 9, 2025, 16:22 PM -
Real-World Drivers of Adherence in Obesity Highlight the Need for Patient-Centered Interventions
Sep 9, 2025, 16:22 PM -
Public Health and Economic Impact of RSVpreF Vaccination Among Older Adults in Latin America and the Caribbean
Sep 9, 2025, 16:22 PM -
Assessment of Severity Modifiers vs. End-of-Life Criteria in Oncology
Sep 9, 2025, 16:22 PM -
Danicopan: A Dominant Option for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Residual Hemolytic Anemia in Spain
Sep 9, 2025, 16:22 PM -
When Excel Starts Talking Back: Unlocking the Power of Conversational AI for Health Economic Models
Sep 9, 2025, 16:22 PM -
Economic Value of Dupilumab in Preventing and Treating Comorbid Asthma in Pediatric Patients With Atopic Dermatitis: A Cost-Offset Model From the Italian Payer Perspective
Sep 9, 2025, 16:22 PM -
Comparison EQ-5D-Y-3L Responses Between Child Self-Reports and Caregiver Proxy Reports
Sep 9, 2025, 16:22 PM -
Can We Quantify the Financial Impact of Patient-Reported Outcomes on the Value of Oncology Products?
Sep 9, 2025, 16:22 PM -
A Novel View on the Treatment Costs of Relapsed or Refractory Diffuse Large B-cell Lymphoma From the Brazilian Private Healthcare System Perspective: A First- to Third-Line Analysis
Sep 9, 2025, 16:22 PM -
Estimating Costs Avoided by Preventing Recurrences With a BRCA Testing Strategy in High-Risk HER2-Negative Adjuvant Breast Cancer Patients in Spain
Sep 9, 2025, 16:22 PM -
Trends in Hospitalizations and Amputations in Diabetic Foot Ulcers (DFUs) in Germany 2019 to 2024
Sep 9, 2025, 16:22 PM
